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Percutaneous transluminal coronary angioplasty of the in- 
farct-related vessel is being performed with increasing fre- 
quency, both during the acute phase and soon aft:r myocar- 
dial infarction. However, previous reports (L-aj described 
patients with single vessel coronary artery dkxe or with 
multivessel disease in whom angioplasty of only one vessel 
was performed. Coronary bypass urgery is a commonly 
recommended therapy for patients with multivessel coro- 
nary artery disease after recent myocardiat infarction :4). 
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Salutary immediate and long-term results of multivessel 
angioplasty have been described (S-9), bJt results of multi- 
vessel angioplasty early after acute infarcticn have not been 
characterized. The godI of this retrospective study was to 
investigate initial and long-term outcome of multivessel 
angioplasty in patients with recent myocardid infarction. 
ts. Coronary angioplasty of multiple vessels 
pe:-k-.med in selected patients at the dical 
ege of Virginia since October 1979. From Janu 1983 
er 8987, 105 patients (6% of a group of 1,427) 
underwent arngioplasty of two or more vessels within 15 days 
after acute myocardia! infarction, and they represent the 
study group. Selection criteria for multivessel angioplasty in 
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these patients were similar to criteria for multivessel angio- 
plasty in patients without myocardial infarction and in- 
cluded, among others, I) presence ofsevere stenosis of the 
infarct-producing vessel after successful thrombolytic reper- 
fusion and associated significant disease in other vessels that 
warranted revascularization andappeared suitable for core- 
nary angioplasty; 2)occurrence ofpostinfaretion a gina or 
objective signs of ischemia early after infarrtion and evi- 
dence of multivessel disease by angiography; and 3) non-Q 
wave infarction, with suitttble anatomy for multivessel an- 
gioplasty by angiography. Multivessel angioplasty was per- 
formed when there was a reasonable probability ofsuccess- 
fully dilating all major segments; in general, bypass urgery 
was recommended if itcould provide more complete revas- 
cularization. Angioplasty of multiple vessels was never 
performed during evolving myocardial infarction. 
Angioplasty protocol. Patients were given 325 mg of 
aspirin and a calcium channel antagonist I day before the 
procedure and maintained on this regimen for 26 months 
thereafter. Angioplasty was performed with standard equip 
ment and techniques (IO). A!) patients received an intrave- 
nous heparin infusion for at least 24 h after the procedure or 
longer if there was evidence of residual thrombus or dissec- 
tion at the dilated site, or both. 
Angioplasty strategy. Dilation of the infarct-related ves- 
sel was generally performed first, followed by dilating other 
vessels in order of their significance (according tovessel size 
and severity of the lesion). The procedure was done in two 
stages (that is, angioplasty of an additional vessel or vessels 
at a later session) when angiclgraphic results of dilation of the 
firs! vessel warranted obsenption (because of intimal dissec- 
tion, for example), when dik tion of the inrarct-related vecjsel 
was performed “ad hoc” (what is, at the same session as 
diagnostic angiography) or wren there was a large amount of 
“stunned” myocardium. In patients with the latter condi- 
tion, because ofthe increased risk of multivessel angioplasty 
with the attendant potential of multiple abrupt reclosure, a 
second stage procedure was generally performed later in the 
hospitalization period (11). When a totally occluded vessel 
was collateralized bya vessel also with significant s enosis, 
the vessel supplying collateral flow was not dilated first to 
avoid jeopardizing an extenstve myocardial zone in case of 
angioplasty failure. 
I)efiaitions. Multivessel disease was defined as the pres- 
ence Of 150% stenosis in two or more major vessels; 
however, angioplasty was generally not performed in vessels 
with <70% stenosis. Angiographic success was defined as 
>20% improvement i  luminal diameter and ~50% residual 
narrowing after angiopiasty. Clinical success was defined as 
successful dilation of alt vessels or of the most important 
vessel associated with clinical improvement or achievement 
ofasymptomatic status after angioplasty. Clinical recurrence 
w;as defined as return of symptoms or objective signs of 
ischemia fter initial improvement and angiographic evi- 
Table 1. Clinical Characteristics of 105 Patients 
Undergoing Multivessel Coronary Angioplasty Early After 
Mvocardial Infarction 
Mean age f SD (yr) 
Gender (M/F) 
Hypertension 
Diabetes mellitus 
Hypercholesterolemia 
Smoking history 
Remote MI 
Prior CABG 
Prior thrombolysis 
Postinfarction angina 
Ml location 
Anterior 
Inferior 
Lateral 
LVEF 
Time from Ml to PTCA 
Staged PTCA 
57 + 11 (range 32-85) 
77 (73%0)/2g (27%) 
39 (37%) 
17 (16%) 
32 130%) 
55 (53%) 
8 (8%) 
7 (7%) 
28 (27%) 
70 (67%) 
78 (74%) 
25 (24%) 
2 (2%) 
58 p+ IO% 
5 t 4 days (range 0-W 
59 (56%) 
CABG = coronary artery bypass grafting: F = female; LVEF = left 
ventricular ejection fraction: M = male; Ml = myocardial infarction; PTCA = 
percutaneous translummal coronary angioplasly. 
dence of restenosis. Complications were 
ously described (12) and classified as major when m 
infarction, urgent bypass urgery or death 
Follow-up. Long-term follow-up data 
periodic office visits or by telepho interviews by a trained 
nurse. Angina1 status, Canadian eart Association func- 
tional class, medication requirement and specific events 
such as death, m:iocardial infarction and bypass urgery 
were recorded. Actuarial life table analysis was performed 
(13) for specific follow-up events (myocardial infarction, 
death, bypass urgery, repeat angioplasty). 
Statistics. Statistical nalysis was performed using a chi- 
square test for discrete variables and a t test for continuous 
variables. A p value CO.05 was considered significant. All 
data are presented as the mean value + SD. 
Patient characteristics (Table I). Of a total of 1,727 pa- 
tients who underwent angioplasty from January 1983 
through December 1987, I05 (6%) had multivessel angio- 
plasty within 2 weeks after acute myocardial infarction: they 
represent 16% of the 656 patients who had angioplasty of
multiple vessels at the Medical College of Virginia up to 
December 1987. The majority (73%) of patients were men, 
8% had a prior remote infarction and 7% had prior bypass 
surgery; 97 patients (92%) and a recent Q wave infarction 
and 8 (8%) had a non-Q wave myocardial infarction before 
angioplasty. Infarct location was aZterir>r in 78 patients 
(74%), inferior in 25 (24%) and lateral in 2 (2%); 70 patients 
(67%) had postinfarction angina nd 28 (27%) had prior 
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No. % 
- 
Extent of CAD 
2 vessel 71 68 
3 vessel 34 3, - 3 
Type of PITA 
2 vessel !@ 86 
3 vessel 15 14 
Lesions attempted 319 3/pl. (range 2-9) 
Success 302 9.5 
Vessels attempled 25’ 2.41~~. (range 2-4) 
Success 237 94 
All vessels success 93 89 
Total occlusions 38 36 
Success 32 84 
-- 
CAD = coronary artery disease: pt. = patient: PTCA = percutaneous 
translumimd coronary angioplasty. 
nant tissue-type ~~asrn~~oge~ activator). ‘The mean left ven- 
tr~cu~ar ejection fraction was 58 ? 90% (range 27% to 78%) 
5% in 13 patients (12%) and <3O% i 
patient was in cardi0ge~ic shock at 
The mean time from acute myocardial infarction to an- 
gioplasty was 5 2 4 days (range O to 151. A staged procedure 
was done in 5? patients (56%) (mean interval between the 
first and second stage, 6 + 4 days). %n 36 (61%) of the 59 
patients undergoing a two stage procedure, the first proce- 
dure was done <7 days after the acute event (mean 3.1), 
most patients being still in the coronary care unit, and in 
these patients, the indication for staging was recent infarc- 
tion with a large amount of stunned myocardium. The other 
23 patients underwent first stage angioplasty >? days after 
infarction (mean 10.4); the indication for staging in these 
patients was large areas of myocar~ium at risk supplied by 
the vessels requiring dilation. 
Although no patient had multivessel a~gio~lasty during 
evolving infarction, one patient had a Srst stage angioplasty 
during the acute phase because of contrakdications to 
thrombolysis (bleeding diathesis) in the setting of extensive 
anterior infarction warranting intervention. Angioplasty of a 
totally occluded left anterior descending artery (the infarct- 
producing vessel) was performed in the acute stage of 
infarction, and an additio~a9 98% proximal circumflex artery 
stenosis was successfu99y dilated IO days later before hospi- 
ta9 arge . 
edMe swcess, AH patients had severe multivessel 
disease, with a majority having two vessel disease (n = 71 
[680/o]), whereas 34 (32%) had three vessel disease: 90 
patients underwent two vessel and 9.5 had three vessel 
angioplasty (Table 2). Overall, a total of 319 lesions (3 
T:l’bie 3. MOW-Up Results in MZ Patieflts Alter Merltivessel 
A%jioglas!y 
I_-.- __- 
Pmrdliate clinicd success ?0?/105 197%) 
Mean fdlow-~~~ !mo., 31 b&e G-73) 
Clinical recurrence 24 (23% b 
Succes epeat PI-CA ?W21 195%) 
Late C 5 (4.9%) 
Late MI 10 (9.89&c, 
Cardiac death 5 (4.W) 
Event free’ 83 @8%7c) 
Asymptomatic 75 (74%) 
Continued success+ 81(86%tl 
“No rnyocurdial infarction. death or bypass surgery; *improvement with- 
out bypass surgery. Abbreviations a5 in Table I. 
lesions per patient, range 2 to 9) and 252 vessels (2.4 vessePs 
r Mient, range 2 to 4) were attempted w 
ions 695%) and 237 ve?;sels (94%); 32 ( 
vessels were success 
n al9 vessels in which 
obtained in 93 patients (89%): clinica success was achieved 
I i~~arct~0~ occurred during or 
ients (5.7%); of these, only one 
enzyme 
ations consistent wit ocardial 
infarction (the mean creatine kinase level was 538 [J/liter, 
with upper normal values being 350 U/liter 
O U/liter for women in ollr 9ab~rat~ry). 
espite evidence of myocardial infarction, these patients 
were cBinica99y improved after the procedure. Urgent bypass 
surgery was performed in two patients (1.9%) because of 
unresolved in-laboratory acute closure; one of t 
tients, who had acute closure of a dominant right coronary 
artery during stiond stage angiopiasty after successful dila- 
tion of a totally occluded left anterior descending artery 5 
days earlier, died of a low output syndrome 24 h after bypass 
surgery. In total. a major complication occurtzd in seven 
patients (7%). Oilier complications included one entry site 
femoral artery pseudoaneurysm, which was repaired sorgi- 
tally 4 days after angioplasty. 
“ti 3). All 902 patients with immediate 
clinica success cotnpleted at least I year of follow-up 
evaluation (mean 39 2 92 months, median 30, range 92 to 
13); follow-up data were obta~~.ed through April 1989. Clin- 
ical recurrence occurred in 24 patients (23%) and 2 additiQ~a~ 
patients had recurrent symptoms due to progression of the 
disease in nondilated vessels. The majority (n = 21) of the 24 
patients with recurrence were treated With repe 
angioplasty, which was successful in 20 (95%); 
with an unsuccessful procedure underwent elective 
surgery later in the hospital stay. Two of the offier ihree 
patients with recurrence were treated with medical therapy 
and the third with elective bypass surgery. Bypass surgery 
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Figure 1. Life table analysis of Survival after muhivesse~ angio- 
plasty early after myocardial infarction; 94% of patients are alive at 
24 months. 
was also performed electively during the follow-up eriod in 
; of the 20 patients who underwent successful repeat angio- 
plasty because of a second recurrence associated with pro- 
gression of coronary artery disease considered unsuitable for 
further dilation. 
Ten patients (9.8%) had a myocardial infarction, which 
was fatal in two during the follow-up eriod. The infarction 
occurred in a previously dilated vesse! in 5 of the IO patients 
and was therefore the manifestation f clinical recurrence. 
Seven patients died during the follow-up eriod at a mean of 
13 * 9 monrhs after angioplasty. Death was caused by a 
malignant tumor in two patients and of cardiac origin in five 
(4.%). Cardiac death was due to myocardial infarction in 
two patients, one of whom had angiographically documented 
restenosis of a previously dilated left anterior descending 
artery; the other three cardiac deaths were sudden. All 
patients who died of cardiac death ad sustained an anterior 
myocardial infarction before angioplasty. The mortality rate 
during the follow-up eriod was thus 2% per year; however, 
four patients died during the 1st year after angioplasty (mean 
4.7 months), one patient during the 2nd year (mean 12.1 
months). Likewise, late myocardial infarction occurred ur- 
ing the 1st year in five patients (mean 8months) and later in 
the other five patients (mean 28.7 months). 
In total, including repeat angioplasty, 83 patients (81%) 
are free of major events (myocardial infarction, death, 
bypass urgery) and 88 (86%) maintain clinical improvement 
(75 [740/o] are asymptomatic and 13 are in Canadian Heart 
Association functional cIass I) without need of surgical 
revascularization during the follow-up eriod. The actuarial 
Sut+vai rate at 24 months was 94%, and 85% of the patients 
are alive without myocardial infarction or need for bypass 
surgery 2years after angioplasty (Fig. I and 2). 
N0NTH.E 
Figure 2. Life table analysis of event-free (no death, myocardial 
infarction, bypass surgery) survival after multivessel angioplasty 
early after myocardial infarction: 85% of patients are event-free at
24 months. 
myocardial infarction. The prognosis of such patients IS 
significantly less favorable than that of patients with single 
vessel disease: the former e resent 27% to 57% of patients 
studied with angiography after acute myocardial infarction 
(14-17). In a study by the Thombolysis and Angioplasty in
Myocardial Infarction (TAM) investigators (161, patients 
with multivessel disease had a higher in-hospital mortality 
rate than did those with single vessel disease after infarction 
(11.6% versus 4.2%) (the number of diseased vessels was the 
second most powerful predictor of survival, after noninfarct 
zone wall motion). The number of diseased vessels together 
with ejection fraction and congestive heart failure in the 
coronary care unit phase were the only independent predic- 
tors of long-term survival in a prospective study (16) corre- 
lating angiographic data with postinfarction survival (mean 
follow-up time 34 months). In a study analyzing long-term 
follow-up data from patients treated with coronary angio- 
plasty for acute myocardial infarction, 53% of whom had 
multivessel disease, Kander et al. (17) indicated that multi- 
vessel disease is a significant univariate predictor of recur- 
rent infarction and death during the follow-up eriod. These 
studies (14-17) emphasize the need for early detection and 
revascularization. Although bypass surgery is the most 
common method of revascularization in patients with multi- 
vessel disease after infarction (4,18), our study indicates that 
coronary angioplasty of multiple vessels can be effectively 
applied in selected patients with severe two and three vessel 
coronary disease arly after infarction. This application of
multivessel angioplasty is not addressed in the American 
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le vessels in 105 patients over a 
,6). This reflects careful patient selection 
in that all patients bad multivessel disease suitable for 
coronary angioplasty; bypass surgery was recommended if 
this could afford more complete revascularization or lower 
risk. Therefore, the study group does not represent all 
patients with severe multivessel disease who will be candi- 
dates for revascularization after acute myocardial Infarction. 
However, 16% of patients undergloing multivessel coronary 
angioplasty at our institution have had the procedure per- 
formed within 15 days of acute infarction. 
ications. The 7% complication rate encountered in 
t group does not appear to be higher than the rate 
of 3.8% to 10% observed with multivessel angioplasty in 
patients without recent infarction in our institution and 
reported by others (5-7) experienced in complex angio- 
plasty. This may be the result of a strategic approach 
designed to minimize risk: the infarct-producing vessel was 
generally dilated first and a vessel supplying collateral now 
was usually not dilated as a rimary vessel; if the collater- 
alized vessel did not appear technically suitable for angio- 
plasty, bypass surgery was recommended to provide ade- 
quate revascularization. It is important to emphasize that no 
patient underwent multivessel angioplasty during evolving 
; the other vessel 
ion rant reversi 
farct~o~ reported a hospital mortality rate of 5.7%, which is 
similar to the hospital mortal rate of 5% observed in a 
series of 300 patients who h bypass surgery for 
Follow-up evaluation during a mean period of 
2.5 years indtcates that satisfactory long-term results can be 
achieved with multivessel angioplasty after recent infarc- 
tion, wit& 74% of patients asymptomatic and 85% alive 
without a second infarction or in need of bypass surgery. 
The clinical recurrence rate of23% compares favorably with 
that reported (7) after multivessel coronary angioplasty in 
patients witholrt recent myocardial infarction. As indicated 
by previous reports (5.6). the majority of pat 
restenosis are suitable for repeat angioplasty. 
actuarial survival and event rates during follow-u 
comparable with those obtained with bypass surgery after 
recent myocardial infarction (18); the actuarial survival rate 
patients who bad bypass surgery for 
angina was 96% at I year and 88 f 4% at 5 years, with a 
mortality rate of 2.7% per year. 
. This retrospective study suggests that mul- 
tivessel angioplasty can be a safe and effective therapy for 
selected patients with severe multivessel disease early after 
acute myocardial infarction. Several prospective random- 
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ized studies such as the BAR1 (Bype:Q-Angioplasty- 
Revascularization Investigation) and the EAST (Emory An- 
gioplasty Surgery Trial) are underway and will help 
characterize the relative fficacy of angioplasty compared 
with bypass surgery in this very important subgroup of 
patients with multivessel coronary artery disease. 
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